论文部分内容阅读
目的以43例糖尿病足为例,旨在探究血栓通联合丁咯地尔治疗该疾病的临床疗效。方法将2016年1月—2017年1月该院收治的86例糖尿病足患者纳入研究,采用盲选法将其分为两组,对照组43例给予常规糖尿病足治疗,观察组43例在此基础上给予血栓通联合丁咯地尔治疗,对比两组治疗效果。结果在治疗总有效率上,观察组为83.72%,对照组为65.12%,明显低于观察组,两组数据差异有统计学意义(P<0.05);治疗后,观察组的Hcy、MMP-9水平显著低于对照组,而VB12水平显著高于对照组,两组数据差异有统计学意义(P<0.05)。结论血栓通联合丁咯地尔治疗糖尿病足,疗效显著,值得采纳应用。
Objective To study the clinical efficacy of Xueshuantong combined with buflomedil in the treatment of 43 cases of diabetic foot. Methods From January 2016 to January 2017, 86 diabetic foot patients admitted to the hospital were enrolled in the study. The patients were divided into two groups by blind selection method. In the control group, 43 patients were treated with conventional diabetic foot, and 43 patients in the observation group Based on the thrombus combined with buflomedil treatment, the two groups compared the therapeutic effect. Results The total effective rate was 83.72% in the observation group and 65.12% in the control group, which was significantly lower than that in the observation group (P <0.05). After treatment, the levels of Hcy and MMP- 9 levels were significantly lower than the control group, while the VB12 level was significantly higher than the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion Xueshuantong combined with buflomedil treatment of diabetic foot, significant effect, it is worth to adopt.